21
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Tight Junction Proteins and Signaling Pathways in Cancer and Inflammation: A Functional Crosstalk

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The ability of epithelial cells to organize through cell–cell adhesion into a functioning epithelium serves the purpose of a tight epithelial protective barrier. Contacts between adjacent cells are made up of tight junctions (TJ), adherens junctions (AJ), and desmosomes with unique cellular functions and a complex molecular composition. These proteins mediate firm mechanical stability, serves as a gatekeeper for the paracellular pathway, and helps in preserving tissue homeostasis. TJ proteins are involved in maintaining cell polarity, in establishing organ-specific apical domains and also in recruiting signaling proteins involved in the regulation of various important cellular functions including proliferation, differentiation, and migration. As a vital component of the epithelial barrier, TJs are under a constant threat from proinflammatory mediators, pathogenic viruses and bacteria, aiding inflammation and the development of disease. Inflammatory bowel disease (IBD) patients reveal loss of TJ barrier function, increased levels of proinflammatory cytokines, and immune dysregulation; yet, the relationship between these events is partly understood. Although TJ barrier defects are inadequate to cause experimental IBD, mucosal immune activation is changed in response to augmented epithelial permeability. Thus, the current studies suggest that altered barrier function may predispose or increase disease progression and therapies targeted to specifically restore the barrier function may provide a substitute or supplement to immunologic-based therapies. This review provides a brief introduction about the TJs, AJs, structure and function of TJ proteins. The link between TJ proteins and key signaling pathways in cell proliferation, transformation, and metastasis is discussed thoroughly. We also discuss the compromised intestinal TJ integrity under inflammatory conditions, and the signaling mechanisms involved that bridge inflammation and cancer.

          Related collections

          Most cited references188

          • Record: found
          • Abstract: found
          • Article: not found

          Inflammation and cancer: advances and new agents.

          Tumour-promoting inflammation is considered one of the enabling characteristics of cancer development. Chronic inflammatory disease increases the risk of some cancers, and strong epidemiological evidence exists that NSAIDs, particularly aspirin, are powerful chemopreventive agents. Tumour microenvironments contain many different inflammatory cells and mediators; targeting these factors in genetic, transplantable and inducible murine models of cancer substantially reduces the development, growth and spread of disease. Thus, this complex network of inflammation offers targets for prevention and treatment of malignant disease. Much potential exists in this area for novel cancer prevention and treatment strategies, although clinical research to support targeting of cancer-related inflammation and innate immunity in patients with advanced-stage cancer remains in its infancy. Following the initial successes of immunotherapies that modulate the adaptive immune system, we assert that inflammation and innate immunity are important targets in patients with cancer on the basis of extensive preclinical and epidemiological data. The adaptive immune response is heavily dependent on innate immunity, therefore, inhibiting some of the tumour-promoting immunosuppressive actions of the innate immune system might enhance the potential of immunotherapies that activate a nascent antitumour response.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells.

            The transactivation of TCF target genes induced by Wnt pathway mutations constitutes the primary transforming event in colorectal cancer (CRC). We show that disruption of beta-catenin/TCF-4 activity in CRC cells induces a rapid G1 arrest and blocks a genetic program that is physiologically active in the proliferative compartment of colon crypts. Coincidently, an intestinal differentiation program is induced. The TCF-4 target gene c-MYC plays a central role in this switch by direct repression of the p21(CIP1/WAF1) promoter. Following disruption of beta-catenin/TCF-4 activity, the decreased expression of c-MYC releases p21(CIP1/WAF1) transcription, which in turn mediates G1 arrest and differentiation. Thus, the beta-catenin/TCF-4 complex constitutes the master switch that controls proliferation versus differentiation in healthy and malignant intestinal epithelial cells.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Wnt signaling in cancer.

              Aberrant regulation of the Wnt signaling pathway is a prevalent theme in cancer biology. From the earliest observation that Wnt overexpression could lead to malignant transformation of mouse mammary tissue to the most recent genetic discoveries gleaned from tumor genome sequencing, the Wnt pathway continues to evolve as a central mechanism in cancer biology. This article summarizes the evidence supporting a role for Wnt signaling in human cancer. This includes a review of the genetic mutations affecting Wnt pathway components, as well as some of epigenetic mechanisms that alter expression of genes relevant to Wnt. I also highlight some research on the cooperativity of Wnt with other signaling pathways in cancer. Finally, some emphasis is placed on laboratory research that provides a proof of concept for the therapeutic inhibition of Wnt signaling in cancer.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Physiol
                Front Physiol
                Front. Physiol.
                Frontiers in Physiology
                Frontiers Media S.A.
                1664-042X
                23 January 2019
                2018
                : 9
                : 1942
                Affiliations
                [1] 1Division of Translational Medicine, Research Branch, Sidra Medicine , Doha, Qatar
                [2] 2Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center , Omaha, NE, United States
                [3] 3Translational Research Institute, Academic Health System, Hamad Medical Corporation , Doha, Qatar
                [4] 4Laboratory Animal Research Center, Qatar University , Doha, Qatar
                [5] 5Department of Biological and Environmental Sciences, Qatar University , Doha, Qatar
                Author notes

                Edited by: Marco Falasca, Curtin University, Australia

                Reviewed by: Karen Yvonne Stokes, LSU Health Sciences Center New Orleans, United States; Shikha Prasad, Feinberg School of Medicine, Northwestern University, United States

                *Correspondence: Ajaz A. Bhat, abhat@ 123456sidra.org

                This article was submitted to Gastrointestinal Sciences, a section of the journal Frontiers in Physiology

                Article
                10.3389/fphys.2018.01942
                6351700
                30728783
                a65ea07b-be2f-48d4-8e19-e43c8125da8d
                Copyright © 2019 Bhat, Uppada, Achkar, Hashem, Yadav, Shanmugakonar, Al-Naemi, Haris and Uddin.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 09 April 2018
                : 22 December 2018
                Page count
                Figures: 5, Tables: 1, Equations: 0, References: 217, Pages: 19, Words: 0
                Categories
                Physiology
                Review

                Anatomy & Physiology
                tight junction,claudin,signaling molecules,tumor,metastasis
                Anatomy & Physiology
                tight junction, claudin, signaling molecules, tumor, metastasis

                Comments

                Comment on this article